Fuad El-Hibri is the founder and executive chairman of the board of Emergent BioSolutions, Inc., of Rockville, Maryland. In this role, Fuad El-Hibri has maintained sales and profitability in the manufacture of vaccines for tuberculosis and influenza. Seeking to encourage further progress in basic and translational research, Mr. El-Hibri serves on the board of trustees of the International Biomedical Research Alliance.
The International Biomedical Research Alliance is a multidisciplinary group whose members include the National Institutes of Health, Cambridge University, and Oxford University. The alliance’s Scholars Program brings in students from the United States and Europe to conduct research with experts in the member institutions. The four-year endeavor enables students to pursue research agendas in the United States and the United Kingdom.
The scholars thrive in a results-oriented culture that promotes accessibility and permits them to work in open collaboration. They work with mentors who often come from biomedicine and other fields, such as mathematics and physics. This process frequently produces new discoveries, and every graduate of the program has single-authored one or more peer-reviewed articles.
Fuad El-Hibri is the founder and executive chairman of Emergent BioSolutions, Inc., a biopharmaceutical company based in Rockville, Maryland. In addition to his professional pursuits, Fuad El-Hibri oversees the El-Hibri Charitable Foundation, which presented its most recent annual Peace Education Prize to author and teacher Dr. Betty A. Reardon.
A highly respected figure in the peace education community, Dr. Betty Reardon has worked as a peace educator since the 1950s. Over the course of her career, she has authored hundreds of books, articles, and teaching materials that helped lay the foundation for the field of peace studies.
In addition to her writing, Dr. Reardon has influenced thousands of educators and thought leaders through her role as a professor at Teachers College, Columbia University. At Columbia, she served as the founding director of the Peace Education Center and helped create the school’s peace education program, which has functioned as a model for similar programs of study at institutions around the world.
Currently, Dr. Reardon is a consultant and founding director emeritus for the International Institute on Peace Education, as well as the founding academic director of the Global Campaign for Peace Education for the Hague Appeal for Peace. Her previous awards include the Sean McBride Peace Prize and an honorable mention by the UNESCO Prize for Peace Education.
Internationally recognized for his achievements in the medical technology industry, Fuad El-Hibri is the founder and executive chairman of Emergent BioSolutions of Rockville, Maryland. The former CEO of Emergent, Fuad El-Hibri was responsible for the oversight and development of various pharmaceuticals and was named Biotech CEO of the Year at the World Vaccine Congress in 2011.
The largest vaccine conference on the planet, the World Vaccine Congress takes place annually in Washington, DC, and recognizes innovation in the pharmaceutical industry. More than 60 percent of conference attendees come from biotech, pharmaceuticals, and government bodies, and represent North America, Europe, Asia, the Middle East, and Africa.
Various award categories are represented each year, and they can include anything from best clinical trial site to best early-stage biotech company. Each award has its own unique set of criteria for which ViE panels judge. To be recognized as the Biotech CEO of the year, candidates’ abilities to grow business from an early stage to mature company is taken into consideration. Judges also look at licensing and partnerships deals, acquisition of new funds, and other factors.